Joining the global race to find solutions to the ongoing SARS-CoV-2 pandemic, IGY Life Sciences is developing one of the first polyclonal antibodies for the treatment of COVID-19. IGY-110 is an ...

Most antibodies used by researchers are either polyclonal — a mixture of antibodies derived from the serum of immunized animals — or monoclonal, where a single specific clone comprises the ...

Each year, over two million people fall victim to snakebites, resulting in more than 100,000 fatalities and 300,000 severe ...

Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...

Learn about our Editorial Policies. Scientists create monoclonal antibodies by cloning a single antibody-producing cell line. In contrast to polyclonal antibodies, monoclonals are highly specific to ...

Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus ...

GFP, expanding its portfolio of secondary antibodies for life science research. GFP is widely used to monitor protein ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

For some HIV vaccines, repetitive immunizations lead to a chain reaction of antibody production against immune complexes already bound to viral proteins.